 |
Dr. H. Michael Shepard, President & CEO, Enosi Life Sciences, USA |
 |
Dr. Tom Blundell, Professor, University of Cambridge, UK |
 |
Dr. Ulo Langel, Professor, Stockholm University, Sweden |
 |
Dr. Mats Larsson, Professor, Department of Physics, Stockholm University, Sweden |
 |
Dr. Maria Koufali, Managing Director, Research and Innovation, Nottingham University Hospitals NHS Trust, UK |
 |
Dr. Ferenc Hudecz, Professor, Department of Organic Chemistry, Eötvös L. University, Hungary |
 |
Dr. Sergey Suchkov, Professor, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Russia |
 |
Dr. Jian Yang, Senior Director, Digital Heath, Eli Lilly and Company, USA |
 |
Dr. Yehuda Shoenfeld, Professor, Sheba Medical Center, Tel-Aviv University, Israel |
 |
Dr. Arne Staby, Scientific VP, CMC Project Management, Biologics, Novo Nordisk A/S, Denmark |
 |
Dr. Michael Markert, Vice President and Global Head of CardioMetabolic Diseases Research, Boehringer Ingelheim, Germany |
 |
Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, AstraZeneca UK Limited, UK |
 |
Dr. Ved Srivastava, Vice President of Peptide Chemistry, Intarcia Therapeutics, USA |
 |
Dr. Sylvie Pucheu, Founder and CSO, CILcare, France |
 |
Dr. Andreas Seidl, Chief Operating Officer, Leukocare AG, Germany |
 |
Dr. Wilfried Dathe, External Consultant and Head of Medical Research, Heck Bio-Pharma GmbH, Germany |
 |
Dr. Tomoko Mineno, Professor, Takasaki University of Health and Welfare, Japan |
 |
Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland |
 |
Dr. Klaus Groschner, Professor, Chair of Biophysics, Medical University of Graz, Austria |
 |
Dr. Yiqun Li, Head of IT Lilly Biotechnology Center, Eli Lilly and Company, USA |
 |
Dr. Joerg Grosse-Onnebrink, Head, University Children’s Hospital Münster, Germany |
 |
Dr. Steve Gardner, CEO, PrecisionLife Ltd, UK |
 |
Dr. Zhenghong Qin, Professor, Soochow University School of Pharmaceutical Science, China |
 |
Dr. Monika Tandon, Senior Vice President & Head, Glenmark Pharmaceuticals, India |
IDDST-2023 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at IDDST-2023
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition
Hall
  |
Exhibition Date: |
 |
 |
 |
 |
 |
 |
 |
 |
International Transmembrane Transporter Society
International Society of Digital Medicine
The Asian Society of Natural Products
UK Pharmacogenetics and Stratified Medicine Network
The Czech Pharmaceutical Society
The National Hospital Pharmacists Association of Romanian
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
© 2003-2023 All rights reserved by BITeomics |